Oklahoma SB1551 prohibits direct-to-consumer pharmaceutical advertising and sets administrative penalties.
Oklahoma SB1551 defines "direct-to-consumer pharmaceutical advertising" as any promotional communication targeting consumers through various media that markets prescription drugs. The bill prohibits any person or entity from engaging in such advertising within the state. The State Board of Pharmacy is authorized to assess administrative penalties for violations. The act is set to become effective November 1, 2026.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.